profit from every $100 of sales.

Science Applications International
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2026.
You pay $17.58 for every $1 of profit it makes in a year.
of earnings would pay off all its debt.
Money in, money out
What Science Applications International sold, what it kept, and what it did with the cash.
Sales went from $7.70 billion in 2023 to $7.26 billion in 2026, with $358 million of profit last year.
Science Applications International handed back 89% of the cash it generated last year.
Science Applications International vs. similar companies
Science Applications International grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Science Applications International | 17.6× · Fair price | ||
IBM | 22.0× · Fair price | ||
Accenture | 17.7× · Fair price | ||
Tata Consultancy Services | 17.7× · Fair price | ||
Infosys | 15.0× · Fair price |
AI analysis
An AI analyst reads Science Applications International's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| 7,056 | 7,394 | 7,704 | 7,444 | 7,479 | 7,262 | |
| 792 | 859 | 888 | 872 | 892 | 872 | |
| 390 | 462 | 514 | 501 | 563 | 521 | |
| 572 | 628 | 650 | 882 | 694 | 664 | |
| 211 | 279 | 300 | 477 | 362 | 358 | |
| 3.56 | 4.77 | 5.38 | 8.88 | 7.17 | 7.70 | |
| 11.2% | 11.6% | 11.5% | 11.7% | 11.9% | 12.0% | |
| 5.5% | 6.2% | 6.7% | 6.7% | 7.5% | 7.2% | |
| 3.0% | 3.8% | 3.9% | 6.4% | 4.8% | 4.9% |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Total assets | 5,723 | 5,746 | 5,543 | 5,314 | 5,246 | 5,354 |
| Cash | 171 | 106 | 109 | 94 | 56 | 182 |
| Total debt | 2,720 | 2,710 | 2,526 | 2,246 | 2,393 | 2,685 |
| Total liabilities | – | – | 3,839 | 3,529 | 3,669 | 3,854 |
| 1,542 | 1,619 | 1,694 | 1,785 | 1,577 | 1,500 | |
| 59 | 58 | 56 | 54 | 51 | 47 | |
| 7.3% | 8.4% | 9.2% | 14.5% | 11.0% | 9.7% | |
| 13.7% | 17.2% | 17.7% | 26.7% | 23.0% | 23.9% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| 755 | 518 | 532 | 396 | 494 | 609 | |
| 46 | 36 | 25 | 27 | 36 | 32 | |
| 709 | 482 | 507 | 369 | 458 | 577 | |
| Dividends paid | 87 | 86 | 83 | 79 | 75 | 70 |
| 34 | 226 | 267 | 382 | 558 | 445 | |
| 42 | 46 | 48 | 68 | 53 | 64 |
Valuation
- 17.6×
- 15.6×
- 1.05
- 3.5×
- 0.9×
- 10.9×
- 13.2×
- 9.2%
- 5.7%
- 1.3%
Profitability
- 12.0%
- 7.2%
- 4.9%
- 9.9%
- 11.9%
- 8.6%
- 27.2%
- 7.6%
- 13.2%
- –
Growth
- +0.6%
- +16.7%
- +26.0%
- +0.0%
- −5.3%
Financial health
- 0.1×
- 0.15
- 4.0%
- 4.2×
- 1.16
- 1.16
- 1.37
How it ranks in Technology
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
What analysts expect
- Average price target
- $97.50
- Range
- $82.00 – $113.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 16, 2026 | 2.62 | 2.31 | +13.4% |
| Dec 4, 2025 | 2.58 | 2.07 | +24.6% |
| Sep 4, 2025 | 2.71 | – | – |
| Jun 2, 2025 | 1.92 | 2.14 | −10.3% |
| Mar 17, 2025 | 2.57 | 2.00 | +28.5% |
| Dec 5, 2024 | 2.61 | 2.17 | +20.3% |
| Sep 5, 2024 | 2.05 | 1.86 | +10.2% |
| Jun 3, 2024 | 1.92 | 1.92 | +0.0% |
Paid per share, each year
$1.18 in 2015 → $1.48 in 2025
How safe it looks
19.6% of its profit
Room to growStretchedMore than it earns: 12.1%
News
The science of vaccines is rapidly advancing — despite the anti-vax movementMarketWatch · Nov 13, 2026Science Applications International prices $500M senior notes offering due 2034Seeking Alpha · Nov 2, 2026SL Science Holding Limited Non-GAAP EPS of $0.00, revenue of $1.38BSeeking Alpha · Oct 26, 2026Colleges raced to build massive computer-science departments. Now the boom is turning to bust.MarketWatch · Oct 21, 2026Influencers and biohackers swear by fasting. Here’s what the science says.MarketWatch · Oct 17, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Science Applications International
Is Science Applications International a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Science Applications International AI analysis
What does Science Applications International do?
Science Applications International Corporation provides technical, engineering, and enterprise information technology (IT) services primarily in the United States. It is in Information Technology Services, based in Reston, VA, United States, with 23,000 employees.
Does Science Applications International pay a dividend?
Yes. At today's price the dividend is 1.3% a year, about 20% of its yearly profit. In 2026 it paid out $70.0 million in dividends.
Is Science Applications International stock halal?
No. Science Applications International does not pass our halal screen: its debt is 43% of its market value, at or above the 33% limit. How we check
How has Science Applications International stock done over the past year?
Up 67.7% over the past twelve months, to $150.24. It traded between $82.22 and $152.91, close to its high.
Who are Science Applications International's competitors?
The largest listed companies in the same industry are IBM, Accenture, Tata Consultancy Services and Infosys. The peers table on this page compares their profit, growth and price with Science Applications International's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.



